News
News
News
16 May 2023
Azelis strengthens its footprint in life sciences with the acquisition of Gillco Ingredients in the USA
News
2 March 2023
FY2022 results: Strong momentum drives 70% growth in adjusted EBITA
Azelis expands into South America with the acquisition of ROCSA in Colombia News20 June 2022Azelis expands into South America with the acquisition of ROCSA in Colombia
Vuk Milojkovic to join Azelis Americas as US Managing Director News20 June 2022Vuk Milojkovic to join Azelis Americas as US Managing Director
Azelis Americas Opens New Headquarters in Mexico City News15 June 2022Azelis Americas Opens New Headquarters in Mexico City
Azelis expands presence in India with the acquisition of Chemo India and Unipharm Laboratories News25 May 2022Azelis expands presence in India with the acquisition of Chemo India and Unipharm Laboratories
Azelis expands its CASE offering with Imerys Performance Minerals News11 April 2022Azelis expands its CASE offering with Imerys Performance Minerals
Azelis strengthens its industrial chemicals footprint in EMEA with the acquisition of WhitChem in the UK News16 March 2022Azelis strengthens its industrial chemicals footprint in EMEA with the acquisition of WhitChem in the UK
Azelis Canada expands CASE offering by adding Hexigone’s Intell-ion® Corrosion Inhibitors News1 December 2021Azelis Canada expands CASE offering by adding Hexigone’s Intell-ion® Corrosion Inhibitors
Azelis opens new CASE laboratory in Istanbul, Turkey News10 November 2021Azelis opens new CASE laboratory in Istanbul, Turkey
Azelis’ Megafarma adds BASF’s performance chemicals portfolio in Mexico News2 November 2021Azelis’ Megafarma adds BASF’s performance chemicals portfolio in Mexico
Azelis announces new distribution agreement with Merck for Surface Solutions in Australia, New Zealand and Indonesia News25 October 2021Azelis announces new distribution agreement with Merck for Surface Solutions in Australia, New Zealand and Indonesia